Tokai Pharmaceuticals (TKAI) IPO Surges Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Tokai Pharma (TKAI) Looks for More Post-IPO Gains
September 18, 2014 7:23 AM EDTTokai Pharma (Nasdaq: TKAI) is adding to Wednesday's gains.
Ahead of the bell, Tokai Pharma is up over 8 percent. The stock closed 58.4 percent higher yesterday following strong IPO pricing and debut.
For more color on Tokai's IPO, click here.
... More